Saturday, 10 October 2026

The week in review

The market regime ended the week at neutral, the close-of-day read from the last trading session, up from the prior risk-off call. The index is strong and the average stock is not. SPY, the exchange-traded fund that tracks the S&P 500, closed at 778.51, which is 7.1% above its 200-day exponential moving average (EMA) of 727.17. Only 398 of 978 names closed above their own 50-day EMA.

Breadth decides the call. At 40.7%, it sits just above the 40% line that would turn the call risk-off and well short of what risk-on requires. Volatility shows no stress: the VIX volatility index was 15.41 at the 8 October 2026 close.

Only the fixed regime rules move the call. It is neutral because no risk-off trigger is met. Risk-on needs breadth at 55% or above while SPY stays at least 5% above its 200-day EMA, or above 60% otherwise (now 40.7%). The call turns risk-off if SPY closes more than 2% below its 200-day EMA (now +7.1%), if breadth falls under 40% (now 40.7%), or if VIX rises above 28 (now 15.41).

This suggests the nearer test of the neutral call is the breadth trigger, since price and volatility sit far from theirs. That view is wrong if breadth reaches 55% while SPY holds at least 5% above its 200-day EMA before it ever closes under 40%.

Rates eased over the week. Federal Reserve data put the 10-year Treasury yield at 5.22% on 8 October 2026, down 6 basis points (hundredths of a percentage point) week over week. The 2-year yield was 4.75%, down 8 basis points. The 10-year minus 2-year spread stood at 0.44% on 9 October 2026, down 1 basis point. Ten-year breakeven inflation was 2.33% on 9 October 2026, down 3 basis points. The real 10-year rate was 2.89% on 8 October 2026, also down 3 basis points.

Credit softened slightly. The high-yield credit spread was 3.15% on 8 October 2026, up 5 basis points week over week. Labor data stayed firm: initial jobless claims were 197K as of 3 October 2026, down 2K week over week, and unemployment was 4.2% as of 1 September 2026. The federal funds rate was 3.75% as of 1 September 2026. Rates, credit and labor data frame the reading. None of them is an input to the call.

Themes in motion

Four themes are accelerating this week: medtech and diagnostics, emerging markets, networking and optical, and Cybersecurity. Analog semiconductors is the only theme the research reads as saturated.

The hardware build-out stories have slowed. The AI datacenter infrastructure theme is maturing, and so is the semi foundry and equipment theme. Meanwhile networking and optical is accelerating. This suggests the research sees momentum shifting from the compute build-out toward the connectivity layer that links it. That reading fails if networking and optical slips to maturing while AI datacenter infrastructure turns back to accelerating.

The rest of the list is maturing: consumer discretionary rotation, oil, energy and geopolitical, and precision biotech and therapeutics. Medtech and diagnostics is accelerating while precision biotech is maturing. This suggests the research favours device and testing stories over drug-development stories within healthcare. The split is wrong if the two themes trade places in status.

Under the lens

This week's research was a broad refresh of 720 dossiers. A refresh of that breadth is maintenance rather than a ranking. The clearest signal of where the research leans is the theme reads above and the dated tests below. Two clusters among the dated events share a story.

• Defense technology at the Association of the U.S. Army show. Draganfly (DPRO), Lantronix (LTRX) and Sidus Space (SIDU) all have the Association of the U.S. Army Annual Meeting & Exposition on their calendars, running 12 October 2026 through 14 October 2026. Lantronix's chief executive is scheduled to meet investors and defense customers there. The grouping means one event tests one story for three small companies: whether defense demand reaches them. Contract or customer announcements tied to the show would support it. Silence afterwards would leave the story unproven.
• Diagnostics reimbursement. Bionano Genomics (BNGO) faces the 11 October 2026 public-comment deadline on a proposed MolDX local coverage determination for genome-wide testing in blood cancers. Insurance coverage is the commercial question for a testing company. The deadline closes comment; the final coverage decision is what settles it.

The week ahead

Next week's dated events are company-specific. They include an Apple product event, a defense exposition, two annual meetings, an investor summit and a futures launch. No macroeconomic release is on this calendar.

• 10 October 2026, Diana Shipping (DSX): the G. P. Zafirakis charter at $38,000/day is expected to start, and the Los Angeles redelivery window closes. A confirmed start puts that day rate into revenue. A delay would break the timing.
• 11 October 2026, Bionano Genomics (BNGO): the comment period closes on the proposed MolDX coverage rule for genome-wide blood-cancer testing. The final determination, which comes later, confirms or breaks the reimbursement case.
• 12 October 2026, CME Group (CME): baseball futures launch. Early trading volume will show whether event contracts add a meaningful new product line.
• 12 October 2026, Credo Technology (CRDO): annual general meeting. Routine on its face, it adds information only if management updates guidance or strategy.
• 12 October 2026, MillerKnoll (MLKN): virtual annual shareholder meeting at 10:30 a.m. Eastern, with a vote on the 2026 Long-Term Incentive Plan. The vote shows how shareholders judge management pay.
• 12 October to 14 October 2026, Draganfly (DPRO), Lantronix (LTRX), Sidus Space (SIDU): the Association of the U.S. Army exposition. Announced orders or partnerships would confirm defense demand. None would leave the case open.
• 13 October 2026, Apple (AAPL): the "Welcome home" product launch event in New York. The products shown will indicate whether Apple's next device cycle has a new category behind it.
• 13 October 2026, Aehr Test Systems (AEHR): the chief executive and chief financial officer present at the 18th Annual CEO Investor Summit in San Francisco. Any order or demand commentary would bear on the semi foundry and equipment theme, which the research reads as maturing.